• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Neurology

Moderate to severe TBI is associated with elevated malignant brain tumor risk

byJayden BerdugoandSimon Pan
September 1, 2025
in Neurology, Oncology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In this retrospective cohort study, moderate to severe traumatic brain injury (TBI) was associated with an increased risk of malignant brain tumour development compared to mild TBI and no TBI.

2. Among the TBI group, a larger number of individuals had a mild TBI compared to a moderate to severe TBI.

Evidence Rating Level: 2 (Good) 

Study Rundown: Traumatic Brain Injury (TBI) has substantial prevalence among the general population and results in increased morbidity and mortality, though the mechanism is not fully understood. Brain tumors, though only confirmed to have an increased risk through ionizing radiation, have shown a potential link through TBI. Studies of military populations, a population with high TBI prevalence, have been limited by confounding factors. To shed some light on inconclusive population studies and to increase early detection of brain tumors, this study investigated whether a link between TBI and malignant brain tumors could be established. This retrospective cohort study used data from US adult civilians across a variety of trauma centres, using codes from the Centers for Disease Control and Prevention for TBI and malignant tumors. Among the exposure group, the majority of the participants had a mild TBI compared to a moderate to severe TBI. Furthermore, there was a larger number of participants in the moderate to severe TBI group who developed a malignant brain tumor compared to the mild TBI group and the control group. One limitation of the study was the inability to determine the specific types of malignant brain tumor associated with TBI. Despite this, the study found that a history of moderate to severe TBI was associated with a future risk of malignant brain tumor development. These results indicate that adults with a history of moderate to severe TBI may benefit from enhanced monitoring and follow-up to identify potential development of malignant brain tumors. To tackle the limitations of this study, future research into screening programs for TBI patients is recommended.

Click here to read the study in JAMA Network Open

Relevant Reading: Traumatic Brain Injury and Subsequent Risk of Brain Cancer in US Veterans of the Iraq and Afghanistan Wars

RELATED REPORTS

2 Minute Medicine Rewind September 1, 2025

Presymptomatic treatment of spinal muscular atrophy with risdiplam leads to improved functional outcomes

Switching to camizestrant after ESR1 mutation detection prolongs progression free survival in advanced breast cancer

In-Depth [retrospective cohort study]: This retrospective cohort study was conducted on 151,358 individuals, split into two equal cohorts of 75,679 participants per group. Participants were included if they were aged 18 years or older and had two or more visits for TBI. Inclusion in the study was limited to a 1-year observation period and a history of prior radiation exposure. Among the Mass General Brigham (MGB) group, the median follow-up time was 7.2 (IQR, 4.1-10.1) years. In the TBI group, 80.3% of participants had mild TBI, and 19.7% had moderate to severe TBI. the incidence of malignant brain tumors was greater in individuals with moderate to severe TBI (87 [0.6%]) compared to those with mild TBI (222 [0.4%]) and the control group (314 [0.4%]) (P=.001). Among matched individuals, the moderate to severe TBI group had a higher rate of malignant brain tumors (87 [0.6%]) compared to the control group (64 [0.4%]) (P=.003). In the regression analysis, individuals with moderate to severe TBI had a significantly higher risk of developing malignant brain tumors (HR, 1.67; 95% CI, 1.31-2.12; P<.001) compared with those with mild TBI (HR, 0.99; 95% CI, 0.83-1.18), independent of confounding factors. Overall, these findings support the need for ongoing monitoring of individuals with moderate to severe TBI to help with earlier detection of malignant brain tumors. 

Image: PD

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: #cancercancer detectionneurologyoncologytbi
Previous Post

2 Minute Medicine Rewind September 1, 2025

RelatedReports

Imatinib safe and effective as long-term treatment for chronic myeloid leukemia: The IRIS trial
Weekly Rewinds

2 Minute Medicine Rewind September 1, 2025

September 1, 2025
California’s cystic fibrosis newborn screening model is highly effective
Chronic Disease

Presymptomatic treatment of spinal muscular atrophy with risdiplam leads to improved functional outcomes

August 29, 2025
Preoperative bilateral breast imaging may reduce contralateral cancer recurrence
Endocrinology

Switching to camizestrant after ESR1 mutation detection prolongs progression free survival in advanced breast cancer

August 28, 2025
One-year of Herceptin preferable to two-year regimen
Endocrinology

Vepdegestrant extends progression-free survival in ER-positive, HER2-negative breast cancer

August 28, 2025

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Moderate to severe TBI is associated with elevated malignant brain tumor risk
  • 2 Minute Medicine Rewind September 1, 2025
  • Significant body weight reduction with cagrilintide-semaglutide therapy
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.